| KIT | PDGFR | TK | 1t46 | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 404 | 0.49 | |
| CLK2 | CLK | CMGC | 6fyl | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10403 | 0.40 | |
| CLK2 | CLK | CMGC | 6khe | A | | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11651 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 6het | A | B | ~{n}-(3-chlorophenyl)-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 11560 | 1.00 | |
| Abl1 (ABL1) | Abl | TK | 1fpu | B | | n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-pyridinecarboxamide | Mouse | 5705 | 0.47 | |
| Abl1 (ABL1) | Abl | TK | 1iep | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5703 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3k5v | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5723 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 6hd6 | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10610 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3mss | B | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5730 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3k5v | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5734 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3k5v | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5722 | 0.49 | |
| EPHA2 (EphA2) | Eph | TK | 6het | A | A | ~{n}-(3-chlorophenyl)-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 11564 | 1.00 | |
| Abl1 (ABL1) | Abl | TK | 3ms9 | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5733 | 0.49 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3pe1 | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 5500 | 0.40 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3pe1 | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 5487 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 6hex | A | A | 4-methyl-3-[(1-methyl-6-pyrazin-2-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11559 | 0.63 | |
| EPHA2 (EphA2) | Eph | TK | 6fnh | B | A | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10421 | 0.48 | |
| EPHB4 (EphB4) | Eph | TK | 6fnj | B | A | 4-methyl-3-[(2-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10340 | 0.59 | |
| EPHA2 (EphA2) | Eph | TK | 6hes | A | B | 4-methyl-3-[(2-pyridin-3-ylquinazolin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11566 | 0.58 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3nga | B | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 5441 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 6fnh | A | B | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10418 | 0.48 | |
| Abl1 (ABL1) | Abl | TK | 6hd6 | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10611 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 6hd4 | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10648 | 0.49 | |
| EPHA2 (EphA2) | Eph | TK | 6fnh | A | A | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10422 | 0.48 | |
| MAPK11 (p38b) | MAPK | CMGC | 3gp0 | A | A | nilotinib | Human | 2768 | 0.47 | |
| MAPK11 (p38b) | MAPK | CMGC | 3gp0 | A | B | nilotinib | Human | 2764 | 0.47 | |
| ABL1 | Abl | TK | 6npu | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10942 | 0.49 | |
| EPHB4 (EphB4) | Eph | TK | 6fni | A | B | 4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10333 | 0.79 | |
| EPHB4 (EphB4) | Eph | TK | 6fnj | B | B | 4-methyl-3-[(2-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10341 | 0.59 | |
| EPHB4 (EphB4) | Eph | TK | 6fnk | A | A | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10344 | 0.48 | |
| EPHA2 (EphA2) | Eph | TK | 8bof | A | B | 4-methyl-~{n}-(3-methylphenyl)-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14652 | 0.88 | |
| CLK1 | CLK | CMGC | 6khd | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11645 | 0.40 | |
| CLK1 | CLK | CMGC | 6khd | C | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11648 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 8bog | A | A | ~{n}-[4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | Human | 14650 | 0.74 | |
| EPHB4 (EphB4) | Eph | TK | 6fni | A | A | 4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10338 | 0.79 | |
| EPHB4 (EphB4) | Eph | TK | 6fnj | A | A | 4-methyl-3-[(2-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10336 | 0.59 | |
| EPHA2 (EphA2) | Eph | TK | 6hes | A | A | 4-methyl-3-[(2-pyridin-3-ylquinazolin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11550 | 0.58 | |
| EPHB4 (EphB4) | Eph | TK | 6fnj | A | B | 4-methyl-3-[(2-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10334 | 0.59 | |
| DDR1 | DDR | TK | 4bkj | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 3263 | 0.49 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3nga | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 5515 | 0.40 | |
| ABL1 | Abl | TK | 5mo4 | A | B | nilotinib | Human | 7526 | 0.47 | |
| PIM1 | PIM | CAMK | 5o11 | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 8657 | 0.40 | |
| DDR1 | DDR | TK | 4bkj | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 3259 | 0.49 | |
| CSF1R (FMS) | PDGFR | TK | 4r7i | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 2307 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3ms9 | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5708 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 6hd4 | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10645 | 0.49 | |
| DDR1 | DDR | TK | 4bkj | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 3255 | 0.49 | |
| CLK1 | CLK | CMGC | 6khd | B | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11644 | 0.40 | |
| CLK3 | CLK | CMGC | 6khf | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11649 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 8boc | A | A | ~{n}-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 15003 | 0.76 | |
| CLK1 | CLK | CMGC | 6khd | B | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11647 | 0.40 | |
| CSNK2A2 (CK2a2) | CK2 | CMGC | 8qbu | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 15029 | 0.40 | |
| ABL1 | Abl | TK | 3pyy | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1049 | 0.49 | |
| CLK4 | CLK | CMGC | 6fyv | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10510 | 0.40 | |
| CLK4 | CLK | CMGC | 6fyv | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10511 | 0.40 | |
| PIM1 | PIM | CAMK | 5o11 | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 8656 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 8bog | A | C | ~{n}-[4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | Human | 14654 | 0.74 | |
| EPHA2 (EphA2) | Eph | TK | 8bof | A | A | 4-methyl-~{n}-(3-methylphenyl)-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14656 | 0.88 | |
| EPHA2 (EphA2) | Eph | TK | 8boh | A | A | 4-methyl-~{n}-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14647 | 0.67 | |
| EPHA2 (EphA2) | Eph | TK | 8boh | A | B | 4-methyl-~{n}-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14651 | 0.67 | |
| EPHA2 (EphA2) | Eph | TK | 8boi | A | B | 4-methyl-~{n}-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14655 | 0.68 | |
| EPHB4 (EphB4) | Eph | TK | 6fnk | A | B | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10337 | 0.48 | |
| MAPK8 (JNK1) | MAPK | CMGC | 8x5m | A | B | 3-[4-(dimethylamino)butanoylamino]-~{n}-[3-methyl-4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | Human | 15100 | 0.42 | |
| HIPK2 | DYRK | CMGC | 6p5s | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11512 | 0.40 | |
| HIPK2 | DYRK | CMGC | 6p5s | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11513 | 0.40 | |
| CLK3 | CLK | CMGC | 6khf | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11650 | 0.40 | |
| CLK1 | CLK | CMGC | 6khd | C | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11643 | 0.40 | |
| EPHA2 (EphA2) | Eph | TK | 8bod | A | B | ~{n}-[3,5-bis(chloranyl)phenyl]-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14646 | 0.91 | |
| EPHA2 (EphA2) | Eph | TK | 8boi | A | A | 4-methyl-~{n}-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14645 | 0.68 | |
| CLK3 | CLK | CMGC | 6fyp | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10400 | 0.40 | |
| CLK3 | CLK | CMGC | 6fyp | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10397 | 0.40 | |
| MAPK8 (JNK1) | MAPK | CMGC | 8x5m | A | A | 3-[4-(dimethylamino)butanoylamino]-~{n}-[3-methyl-4-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide | Human | 15099 | 0.42 | |
| EPHA2 (EphA2) | Eph | TK | 6fnh | C | A | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10415 | 0.48 | |
| EPHA2 (EphA2) | Eph | TK | 6hex | A | B | 4-methyl-3-[(1-methyl-6-pyrazin-2-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11555 | 0.63 | |
| Abl1 (ABL1) | Abl | TK | 3ms9 | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5713 | 0.49 | |
| EPHA2 (EphA2) | Eph | TK | 8bom | A | B | ~{n}-(3-methoxyphenyl)-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14653 | 0.81 | |
| EPHA2 (EphA2) | Eph | TK | 6fnf | A | B | 4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10420 | 0.79 | |
| EPHA2 (EphA2) | Eph | TK | 6hev | A | B | 4-methyl-3-[(2-pyridin-3-ylpyrido[2,3-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11565 | 0.59 | |
| EPHA2 (EphA2) | Eph | TK | 8bok | A | A | ~{n}-(3,5-dimethoxyphenyl)-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14648 | 0.76 | |
| EPHA2 (EphA2) | Eph | TK | 6fng | A | A | 4-methyl-3-[(2-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10414 | 0.59 | |
| EPHA2 (EphA2) | Eph | TK | 6fnf | A | A | 4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10417 | 0.79 | |
| EPHA2 (EphA2) | Eph | TK | 8bog | A | B | ~{n}-[4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]phenyl]-3-(trifluoromethyl)benzamide | Human | 14649 | 0.74 | |
| EPHA2 (EphA2) | Eph | TK | 6heu | A | B | 3-[(4,6-dipyridin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11552 | 0.44 | |
| EPHA2 (EphA2) | Eph | TK | 6hey | A | B | 3-[(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11558 | 0.55 | |
| EPHA2 (EphA2) | Eph | TK | 6fng | A | B | 4-methyl-3-[(2-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 10416 | 0.59 | |
| EPHA2 (EphA2) | Eph | TK | 6hew | A | A | 4-methyl-3-[(1-methyl-6-pyrimidin-5-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11549 | 0.67 | |
| EPHA2 (EphA2) | Eph | TK | 6fnh | C | B | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10419 | 0.48 | |
| EPHA2 (EphA2) | Eph | TK | 8boc | A | B | ~{n}-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 15002 | 0.76 | |
| EPHA2 (EphA2) | Eph | TK | 6heu | A | A | 3-[(4,6-dipyridin-4-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11563 | 0.44 | |
| EPHA2 (EphA2) | Eph | TK | 6hev | A | A | 4-methyl-3-[(2-pyridin-3-ylpyrido[2,3-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11561 | 0.59 | |
| EPHA2 (EphA2) | Eph | TK | 6hey | A | A | 3-[(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)amino]-4-methyl-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11557 | 0.55 | |
| EPHA2 (EphA2) | Eph | TK | 6fnh | B | B | 1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-amine | Human | 10413 | 0.48 | |
| EPHA2 (EphA2) | Eph | TK | 6hew | A | B | 4-methyl-3-[(1-methyl-6-pyrimidin-5-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]-~{n}-[3-(trifluoromethyl)phenyl]benzamide | Human | 11556 | 0.67 | |
| EPHA2 (EphA2) | Eph | TK | 8bod | A | A | ~{n}-[3,5-bis(chloranyl)phenyl]-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14657 | 0.91 | |
| EPHA2 (EphA2) | Eph | TK | 8bom | A | A | ~{n}-(3-methoxyphenyl)-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14658 | 0.81 | |
| EPHA2 (EphA2) | Eph | TK | 8bok | A | B | ~{n}-(3,5-dimethoxyphenyl)-4-methyl-3-[(1-methyl-6-pyridin-3-yl-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide | Human | 14659 | 0.76 | |
| CLK1 | CLK | CMGC | 6khd | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 11646 | 0.40 | |
| CSNK2A2 (CK2a2) | CK2 | CMGC | 8qbu | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 15025 | 0.40 | |
| CSNK2A2 (CK2a2) | CK2 | CMGC | 6hmb | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10994 | 0.40 | |
| CSNK2A2 (CK2a2) | CK2 | CMGC | 6hmb | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10995 | 0.40 | |
| ABL1 | Abl | TK | 3cs9 | B | B | nilotinib | Human | 1112 | 0.47 | |
| ABL1 | Abl | TK | 6npv | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10949 | 0.49 | |
| ABL1 | Abl | TK | 2hyy | C | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1048 | 0.49 | |
| ABL1 | Abl | TK | 6npv | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10948 | 0.49 | |
| ABL1 | Abl | TK | 3pyy | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1098 | 0.49 | |
| ABL1 | Abl | TK | 3pyy | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1071 | 0.49 | |
| ABL1 | Abl | TK | 6npe | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10947 | 0.49 | |
| ABL1 | Abl | TK | 2hyy | B | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1078 | 0.49 | |
| ABL1 | Abl | TK | 6npv | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10950 | 0.49 | |
| ABL1 | Abl | TK | 6npe | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10945 | 0.49 | |
| ABL1 | Abl | TK | 3cs9 | C | A | nilotinib | Human | 1046 | 0.47 | |
| ABL1 | Abl | TK | 2hyy | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1092 | 0.49 | |
| ABL1 | Abl | TK | 3pyy | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1062 | 0.49 | |
| ABL1 | Abl | TK | 3cs9 | C | B | nilotinib | Human | 1093 | 0.47 | |
| ABL1 | Abl | TK | 3cs9 | D | B | nilotinib | Human | 1066 | 0.47 | |
| ABL1 | Abl | TK | 3cs9 | A | A | nilotinib | Human | 1080 | 0.47 | |
| ABL1 | Abl | TK | 6npu | B | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10944 | 0.49 | |
| ABL1 | Abl | TK | 5mo4 | A | A | nilotinib | Human | 7527 | 0.47 | |
| ABL1 | Abl | TK | 2hyy | D | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1068 | 0.49 | |
| ABL1 | Abl | TK | 6npe | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10943 | 0.49 | |
| ABL1 | Abl | TK | 6npv | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10951 | 0.49 | |
| ABL1 | Abl | TK | 6npe | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 10946 | 0.49 | |
| ABL1 | Abl | TK | 3cs9 | A | B | nilotinib | Human | 1107 | 0.47 | |
| ABL1 | Abl | TK | 3cs9 | B | A | nilotinib | Human | 1050 | 0.47 | |
| SYK | Syk | TK | 1xbb | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1196 | 0.49 | |
| SYK | Syk | TK | 1xbb | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 1184 | 0.49 | |
| DYRK1A | DYRK | CMGC | 7z5n | A | | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 14667 | 0.40 | |
| SRC | Src | TK | 1y57 | A | | 4-[(4-methylpiperazin-1-yl)methyl]-n-{3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide | Human | 986 | 0.42 | |
| MAPK14 (p38a) | MAPK | CMGC | 3hec | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 5166 | 0.49 | |
| MAPK14 (p38a) | MAPK | CMGC | 3hec | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 5035 | 0.49 | |
| PDGFRA (PDGFRa) | PDGFR | TK | 5grn | A | B | n-[2-(dimethylamino)ethyl]-n-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]pyridine-3-carboxamide | Human | 9478 | 0.42 | |
| PDGFRA (PDGFRa) | PDGFR | TK | 5grn | A | A | n-[2-(dimethylamino)ethyl]-n-[[4-[[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]carbamoyl]phenyl]methyl]pyridine-3-carboxamide | Human | 9479 | 0.42 | |
| PDGFRA (PDGFRa) | PDGFR | TK | 6jol | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 12103 | 0.49 | |
| KIT | PDGFR | TK | 1t46 | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 393 | 0.49 | |
| GSK3B | GSK | CMGC | 7z1g | A | | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 14662 | 0.40 | |
| GSK3B | GSK | CMGC | 7z1f | A | | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 14663 | 0.40 | |
| ABL2 | Abl | TK | 3gvu | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 109 | 0.49 | |
| ABL2 | Abl | TK | 3gvu | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 117 | 0.49 | |
| LCK | Src | TK | 2pl0 | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 2290 | 0.49 | |
| EPHA7 (EphA7) | Eph | TK | 3dko | A | A | 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide | Human | 1 | 0.40 | |
| EPHA7 (EphA7) | Eph | TK | 3dko | A | B | 5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide | Human | 3 | 0.40 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3nga | B | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 5511 | 0.40 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 3nga | A | A | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 5422 | 0.40 | |
| CLK2 | CLK | CMGC | 6fyl | A | B | 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid | Human | 10404 | 0.40 | |
| Abl1 (ABL1) | Abl | TK | 1opj | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5732 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3mss | C | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5719 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 6hd6 | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10608 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 1iep | B | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5727 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 1opj | B | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5736 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 6hd6 | A | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10609 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3ms9 | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5706 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3mss | D | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5702 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 1fpu | A | | n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-pyridinecarboxamide | Mouse | 5728 | 0.47 | |
| Abl1 (ABL1) | Abl | TK | 6hd4 | B | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10646 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 6hd4 | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 10647 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3k5v | B | A | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5710 | 0.49 | |
| Abl1 (ABL1) | Abl | TK | 3mss | A | | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Mouse | 5724 | 0.49 | |
| DDR1 | DDR | TK | 4bkj | A | B | 4-(4-methyl-piperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide | Human | 3256 | 0.49 | |
| ABL1 | Abl | TK | 3cs9 | D | A | nilotinib | Human | 1077 | 0.47 | |
